Header Logo

Connection

IBRAHIM KHANSA to Acetylcholine Release Inhibitors

Back to Details
This is a "connection" page, showing publications IBRAHIM KHANSA has written about Acetylcholine Release Inhibitors.
IBRAHIM KHANSA
Connection Strength
0.166
Acetylcholine Release Inhibitors
  1. Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches. Plast Reconstr Surg. 2020 Feb; 145(2):401e-406e.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.